SKYLAR GROTH: Open Payments
NPI 1518537158 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,771 in 28 payments from 7 companies in 2025. Trend: 2023 $1,799 · 2024 $981 · 2025 $5,771
Consulting: $2,400Travel & lodging: $2,010Food & beverage: $1,361
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 8 | $3,409 |
| Adaptive Biotechnologies Corporation | 14 | $1,962 |
| Legend Biotech USA Inc. | 2 | $139 |
| Gamida Cell Inc. | 1 | $106 |
| Syndax Pharmaceuticals, Inc. | 1 | $97 |
| Teleflex LLC | 1 | $38 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: clonoSEQ, CARVYKTI, Niktimvo, OMISIRGE, REVUFORJ, ARROW, KEYTRUDA.
Industry payments across TX — which companies pay providers there.
